about
Chitosan based hydrogels: characteristics and pharmaceutical applicationsNanoparticulate adjuvants and delivery systems for allergen immunotherapyAn Overview of the Medical Applications of Marine Skeletal Matrix ProteinsStable dry powder formulation for nasal delivery of anthrax vaccineA Multiple siRNA-Based Anti-HIV/SHIV Microbicide Shows Protection in Both In Vitro and In Vivo ModelsNasal vaccine innovation.Development of adenoviral vector-based mucosal vaccine against influenza.Alkyl polyglycoside, a highly promising adjuvant in intranasal split influenza vaccines.The mucosal and systemic immune responses elicited by a chitosan-adjuvanted intranasal influenza H5N1 vaccine.The promise of chitosan microspheres in drug delivery systems.A single immunization with a dry powder anthrax vaccine protects rabbits against lethal aerosol challengePreparation of alginate coated chitosan microparticles for vaccine deliveryGranulocyte-macrophage colony-stimulating factor enhances the humoral immune responses of mouse zona pellucida 3 vaccine strategy based on DNA and protein coadministration in BALB/c mice.Construction and immunogenicity of a DNA vaccine coexpressing GP3 and GP5 of genotype-I porcine reproductive and respiratory syndrome virusA novel method for synthesizing PEGylated chitosan nanoparticles: strategy, preparation, and in vitro analysis.Nanoparticles for local drug delivery to the oral mucosa: proof of principle studies.Chitosan: a promising safe and immune-enhancing adjuvant for intranasal vaccines.Intranasal P particle vaccine provided partial cross-variant protection against human GII.4 norovirus diarrhea in gnotobiotic pigs.Pulmonary immunization of guinea pigs with diphtheria CRM-197 antigen as nanoparticle aggregate dry powders enhance local and systemic immune responses.Intranasal DNA Vaccine for Protection against Respiratory Infectious Diseases: The Delivery Perspectives.Antitumor effect of therapeutic HPV DNA vaccines with chitosan-based nanodelivery systems.Enhanced immune response and protective effects of nano-chitosan-based DNA vaccine encoding T cell epitopes of Esat-6 and FL against Mycobacterium tuberculosis infection.Influenza vaccines: present and future.Recent advancement of chitosan-based nanoparticles for oral controlled delivery of insulin and other therapeutic agents.Exploiting fungal cell wall components in vaccinesChitosan nanoparticles act as an adjuvant to promote both Th1 and Th2 immune responses induced by ovalbumin in miceReceptor-mediated gene delivery by folic acid-modified stearic acid-grafted chitosan micelles.Can nonliving nasal vaccines be made to work?Blood stage merozoite surface protein conjugated to nanoparticles induce potent parasite inhibitory antibodiesChitosan solution enhances both humoral and cell-mediated immune responses to subcutaneous vaccination.Nanoparticle-mediated gene delivery: state of the art.Nanotechnology Applications to HIV Vaccines and Microbicides.Nanoparticles as carriers for nasal vaccine delivery.Bacteriophage-mediated protein delivery into the central nervous system and its application in immunopharmacotherapy.Past, present, and future technologies for oral delivery of therapeutic proteins.The potential of chitosan for the oral administration of peptides.Noninvasive delivery technologies: respiratory delivery of vaccines.Immunostimulatory colloidal delivery systems for cancer vaccines.Design and application of chitosan microspheres as oral and nasal vaccine carriers: an updated reviewChitosan-Based Intranasal Vaccine against Escherichia coli O157:H7.
P2860
Q26782711-60D57140-0EBE-4D16-A93B-D7FDB9A48580Q26825418-C05DA90B-6D7B-4818-A8CC-9F17696240D5Q28074092-21CBD5E3-FC13-4359-B009-920DF881D483Q28386405-3805F66C-70CC-4CC2-A357-412BA12D9E17Q30379545-2A7C4528-B75F-421D-B860-E667E4D3FBCBQ30395810-67BD6ABA-09A4-4CC9-90B2-BF8655773031Q30396642-7AA3E103-27BA-4630-B9DB-07435F73E42DQ30397973-981D5ED4-6A6C-459C-956C-B9604B7D4B2DQ30404699-DE88A437-F939-4432-A1AE-31EE6C4D80BBQ31112020-3F416306-FDB1-42C5-B36C-46B8F27880B9Q33360151-25D7BAF0-CA9B-47A2-B3E6-CFE75C011932Q33385532-7EAA295F-D6D2-4350-8056-31A124731496Q33830005-20D2D1B0-A4EA-4768-8C4C-DB8AC07BC6B4Q33876144-DC172F29-BC40-4AFF-827D-AB6D8B40EB67Q33895980-2A76188C-CAC9-45FB-B78F-9AE6A800C1C6Q33906978-41034385-C512-45DE-8B28-4B3EA251DBE1Q34033764-90CE44BD-F366-4F9A-822C-5BB222844A24Q34059409-FDBF36D9-621F-4717-967C-F70A95C8CE40Q34293599-E7719475-C85B-48C9-A5C5-3D5D189458E2Q34309830-9BC72731-D489-4206-9D3F-2DEF8E7D56B2Q34544509-079FE582-6344-46BF-ADFB-7593ED179531Q34700107-2654785B-1E5A-4637-AD02-A0BC2AC11B87Q34717840-D03A49D2-4013-45D7-AC83-3DFEBB59A579Q34733812-5383AC42-5EFC-4BB2-9372-08120EF0AAC6Q35085200-5BC5CE71-D42F-4368-A43D-0E411C361958Q35091726-80EE21C6-0ED2-4167-89AA-EA312E24DA46Q35153708-FE56F144-0E01-4E91-92B7-6312C19D0170Q35193442-51ED98FF-EA3E-4174-A878-479F79D62807Q35456892-3B28B09A-7C34-44C0-9294-1CA8B1400FD2Q35839060-398B061E-841A-46D0-8C2B-1D31B206EF75Q35842597-DE70C71D-CFC0-45FB-B580-D7D37BA2CE40Q35890514-9801493B-B9FD-45EC-BAC9-00600273CDCEQ36124952-D60F9386-5174-4D7D-9ED9-394219980101Q36161215-A7B5A655-F80B-469B-A029-1DC6268BD1CBQ36232650-36622224-EC46-4F42-A448-803BF5F69BD9Q36316822-551F2953-6904-4509-9044-B177CC42DCA9Q36349694-AAE98D2E-4E94-43AD-AE8F-392C94D190EAQ36460849-E91FD801-82E2-4A4F-BF1F-1A7FDCD23139Q36477627-4D5B4468-DF29-4C24-9689-05F850F2E636Q36502198-24575533-5BE9-4E1B-AB17-9315BB6A0393
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Chitosan as a novel nasal delivery system for vaccines.
@ast
Chitosan as a novel nasal delivery system for vaccines.
@en
Chitosan as a novel nasal delivery system for vaccines.
@nl
type
label
Chitosan as a novel nasal delivery system for vaccines.
@ast
Chitosan as a novel nasal delivery system for vaccines.
@en
Chitosan as a novel nasal delivery system for vaccines.
@nl
prefLabel
Chitosan as a novel nasal delivery system for vaccines.
@ast
Chitosan as a novel nasal delivery system for vaccines.
@en
Chitosan as a novel nasal delivery system for vaccines.
@nl
P2093
P1476
Chitosan as a novel nasal delivery system for vaccines.
@en
P2093
Hinchcliffe M
Jabbal-Gill I
P356
10.1016/S0169-409X(01)00171-5
P407
P577
2001-09-01T00:00:00Z